COMPANIES The new chief executive of Sanofi-Aventis plans to expand further into consumer health, generics and biological medicines in his efforts to transform the French pharmaceuticals group.
In an interview with the Financial Times, Chris Viehbacher said that he would shift Sanofi-Aventis from “an EU/US-centric pharma company to a global healthcare company” through acquisitions and internal restructuring.
